Immunotherapy
Immunotherapy is revolutionizing cancer treatment by using the body’s own immune system to fight cancer cells. Learn about the latest advancements, clinical trials, and how this cutting-edge approach is improving patient outcomes.
Kidney cancer study identifies factors for exceptional response to immunotherapy
Metastatic clear cell renal cell carcinoma (mccRCC), an aggressive type of kidney cancer, has historically presented limited treatment options. Immune checkpoint inhibitors, a form of immunotherapy, can lead to exceptional, durable responses (when the tumor substantially shrinks for a very long period of time) for some patients with mccRRC, allowing them to live longer with a better quality of life. However, the molecular reasons behind these exceptional responses have not been well defined.
Grandmother, 53, Beat Stage 4 HER2-Positive Breast Cancer With Immunotherapy After Being Told To 'Enjoy The Time You Have Left'
Grandmother Tina Willits, 53, beat HER2-positive breast cancer and she's praising an immunotherapy treatment for saving her life.
Clinical trial shows cancer-preventing topical immunotherapy trains immune system to fight precancers
A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first to activate specific components of the adaptive immune system, particularly CD4+ T helper cells, which are not known to be involved in traditional cancer treatments.
Bile acids impair liver cancer immunotherapy: A dietary supplement may offer relief
Immunotherapy is a modern approach to cancer treatment that uses a patient’s own immune system to help fight tumors. It has made an incredible impact on treating cancers in many different organ systems, including the lung, kidney, and bladder—but for other cancers, such as liver cancer, the therapy has been much less effective. This discrepancy is especially concerning as liver cancer rates have nearly tripled in the last 40 years.
This Diet Increases Brain Cancer Survival By 66%, Study Finds
Glioblastoma multiforme (GBM) is one of the most aggressive and deadly brain cancers, with a median survival rate of just 12 to 18 months despite surgery, chemotherapy, and radiation. But a recent clinical study1 has uncovered a promising alternative
